A detailed history of Green Square Capital Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Green Square Capital Advisors LLC holds 3,985 shares of NVO stock, worth $422,250. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,985
Previous 3,790 5.15%
Holding current value
$422,250
Previous $540,000 12.22%
% of portfolio
0.07%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.07 - $145.42 $23,218 - $28,356
195 Added 5.15%
3,985 $474,000
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $10,553 - $12,634
86 Added 2.32%
3,790 $540,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $122,532 - $163,103
1,200 Added 47.92%
3,704 $475,000
Q4 2023

Jan 18, 2024

SELL
$87.78 - $105.45 $9,480 - $11,388
-108 Reduced 4.13%
2,504 $259,000
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $120,950 - $265,388
1,330 Added 103.74%
2,612 $237,000
Q2 2023

Jul 13, 2023

BUY
$155.98 - $172.65 $199,966 - $221,337
1,282 New
1,282 $207,000
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $527,762 - $599,139
-11,384 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $17,280 - $19,656
-416 Reduced 3.53%
11,384 $524,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $29,131 - $31,922
623 Added 5.57%
11,800 $556,000
Q2 2018

Aug 20, 2018

BUY
$44.29 - $50.42 $53,856 - $61,310
1,216 Added 12.21%
11,177 $515,000
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $269,895 - $323,607
5,566 Added 126.64%
9,961 $498,000
Q4 2017

Feb 22, 2018

BUY
$47.53 - $53.73 $208,894 - $236,143
4,395
4,395 $236,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Green Square Capital Advisors LLC Portfolio

Follow Green Square Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Square Capital Advisors LLC with notifications on news.